Michael Lamsa

Novozymes (United States)

Papers

3

Total Citations

233

H-Index

2

About

Dr. Michael Lamsa is a pioneering biotechnologist whose research has significantly advanced industrial enzyme production and protein engineering. His most impactful work centers on the heterologous expression of complex enzymes, most notably his landmark 1991 study on achieving commercial levels of chymosin production in *Aspergillus*—a breakthrough that garnered 167 citations and revolutionized the cheese-making industry by enabling a reliable, microbial source of rennet. Dr. Lamsa further demonstrated his expertise in protein optimization through the directed evolution of a maltogenic α-amylase from *Bacillus* sp. TS-25 (2008, 64 citations), enhancing its stability and activity for industrial starch processing. His contributions also extend to laboratory automation, as evidenced by his work on screen automation and robotics (2003), reflecting a commitment to high-throughput methodologies. With over 230 combined citations across his key publications, Dr. Lamsa’s research has had a lasting impact on applied microbiology and bioprocess engineering, bridging fundamental protein science with real-world commercial applications.

Research Focus

Key Achievements

2
H-Index
3
Papers
233
Total Citations
78
Avg Citations/Paper
🏆 Most Cited Paper
Commercial Levels of Chymosin Production by Aspergillus
167 citations · 1991
📈 Most Prolific Year: 1991 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Novozymes (United States)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago